Senior Scientist

Mexico City, Mexico On-site          ·         Full time

About the role

Objectives of the role

As a Senior Scientist at Actipulse Neuroscience, you will be responsible for leading research and development efforts related to TMS technology. This will include designing and conducting experiments to investigate the mechanisms and effects of TMS, as well as analyzing data and interpreting results. To be successful in this role, you should have a strong background in neuroscience and neurotechnology, as well as experience with experimental design and data analysis. You should have a passion for advancing the field of brain stimulation and a desire to develop innovative solutions that can improve the lives of patients. You love a fast-paced environment, but you also know that “fast-paced” can be zen and supportive… ah, and you are not arrogant and treat people the same way you would like to be treated.

Responsibilities

• Lead research and development efforts related to TMS technology
• Design and conduct experiments to investigate the mechanisms and effects of TMS
• Analyze data and interpret results
• Collaborate with other teams, such as engineering and product development, to ensure that research is aligned with overall product goals
• Stay up-to-date with the latest developments in neuroscience and neurotechnology

Qualifications

• Ph.D. in neuroscience or a related field
• Advanced in English, proficiency in Spanish

Abilities

• Excellent communication skills (both oral and written)
• Analytical and data-driven
• Problem solving skills
• Ability to adapt to different situations
• Fast learning
• Focus on objectives

What we offer

• Work on an impactful startup, pursuing the mission of improving quality of life of patients
• Salary
• 20 days of vacations

Why you should join Actipulse Neuroscience

Actipulse Neuroscience is a neuro-technology company focused in brain health. We are specialized in non-invasive brain neuromodulation therapeutics for the treatment of psychiatric and neurological diseases.

Our research pipeline is focused on targeting well known pathogenic mechanisms commonly found in neurodegenerative disorders, in order to slow down disease progression.

Currently in FDA pivotal trial phase.